
As of 08-JUL-2026, promoters held 65.47% of Suven Life Sciences (-4.61 pp from 30-JUN-2026), foreign institutional investors 0.48%, domestic institutions 2.73% and the public 31.32%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Promoters held 65.47% of Suven Life Sciences as of 08-JUL-2026, down 4.61 pp from 70.08% in 30-JUN-2026.
Foreign institutional investors held 0.48% of Suven Life Sciences as of 08-JUL-2026, a change of -0.09 pp from the previous quarter.
Domestic institutional investors, including mutual funds and insurers, held 2.73% of Suven Life Sciences as of 08-JUL-2026 (-0.20 pp from the previous quarter).
As of 08-JUL-2026, Suven Life Sciences' shareholders were promoters (65.47%), foreign institutional investors 0.48%, domestic institutions 2.73% and the public 31.32%, as filed with the stock exchanges.
Track SUVEN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.